Denise Boudreau, PhD earned her doctorate in Pharmaceutical Outcomes Research and Policy from the University of Washington in 2002, and both master's degree in Pharmacy Administration in 1996 and B.Pharm in 1992 from the University of Rhode Island. She is an Affiliate Associate Professor in the Department of Pharmacy. Dr. Boudreau works as a Scientific Investigator at Group Health Center for Health Studies. She is the Group Health site Principal Investigator for the HMO Research Network Center for Education and Research on Therapeutics (CERT).
Dr. Boudreau is involved in a wide array of pharmacoepidemiology and pharmacoeconomic research. She has conducted research in multiple areas, including: general drug safety, medication use and cancer risk, validation of pharmaceutical data sources, cost and effect of medication use on breast cancer biologic and screening endpoints, cost utility of measures to improve mammography screening, economic burden of metabolic syndrome, and pharmacy practice patterns. Her current research projects include: determinants and risks of long term opioid therapy, impact of commonly used medications on breast cancer outcomes, and cost of false positive mammography.